Articles From: AEP To Bid On Canadian Transmission Project to Aeroflex to Participate in Investor Conferences


AEP Transmission Holding Co.
Sign-up for AEP To Bid On Canadian Transmission Project investment picks
COLUMBUS, Ohio , Sept.
Sign-up for AEP To Retire Entire Tanners Creek Plant In Indiana investment picks
2013/9/12
Atmospheric and Environmental Research ( AER ), a Verisk Analytics (Nasdaq:VRSK) company, reports some of the strongest evidence to date that Arctic sea ice loss, which contributes to an overall warmer Arctic, has links to colder winters and related extreme weather events across northern Eurasia and much of the U.S. and Canada.
Sign-up for AER Scientists Uncover Link Between Declining Arctic Sea Ice and Colder Winters investment picks
Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) announced today the closing of its initial public offering of 7,728,000 shares of its common stock, including 1,008,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares to cover over-allotments, at a public offering price of $10.00 per share, before underwriting discounts.
Sign-up for Aerie Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option investment picks
2014/2/25
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced the results of preclinical in vivo research demonstrating the ability of AR-13324 to reduce episcleral venous pressure (EVP) in the eye.
Sign-up for Aerie Pharmaceuticals Announces Study Results Supporting Additional Mechanism of Action for Lead Glaucoma Drug Candidate AR-13324 investment picks
2014/1/30
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company’s Phase 2b study of PG324, a novel, fixed-combination of Aerie’s AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.
Sign-up for Aerie Pharmaceuticals Initiates Phase 2b Study of PG324, a Novel Fixed-Combination Product to Treat Patients with Glaucoma or Ocular Hypertension investment picks
2014/2/24
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Marvin J.
Sign-up for Aerie Pharmaceuticals Names Marvin J. Garrett as Vice President, Regulatory Affairs and Quality Assurance investment picks
2014/3/25
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Richard A.
Sign-up for Aerie Pharmaceuticals Names Richard A. Lewis, M.D., as Chair of Scientific Advisory Board investment picks
2014/3/18
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on the Company’s business highlights.
Sign-up for Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Business and Product Development Update investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced top-line results from the Company’s recently completed Phase 1 pharmacokinetics (PK) study, in which AR-13324 eye drops were administered once-daily to 18 healthy individuals over an eight-day period to assess systemic exposure to the drug.
Sign-up for Aerie Pharmaceuticals Reports Positive Results for Lead Candidate AR-13324 in Normotensive Individuals investment picks
2013/12/4
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported financial results for the third quarter and nine months ended September 30, 2013 and provided an update on the Company’s business highlights.
Sign-up for Aerie Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Business and Product Development Update investment picks
2014/3/6
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) announced today that its fourth quarter and year end 2013 financial results will be released after the market closes on Tuesday, March 18, 2014.
Sign-up for Aerie Pharmaceuticals to Announce Fourth Quarter and Year End 2013 Financial Results and Host Conference Call on Tuesday, March 18, 2014 investment picks
2013/11/20
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced today that its third quarter 2013 financial results will be released after the market closes on Wednesday, December 4, 2013.
Sign-up for Aerie Pharmaceuticals to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, December 4, 2013 investment picks
2014/4/2
Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido, Jr., Ph.D., chairman and chief executive officer, will present at the 13 th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 12:10 pm Eastern Time in New York, NY.
Sign-up for Aerie Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference investment picks
2014/3/5
Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido, Jr., Ph.D., chairman and chief executive officer will present at the 26 th Annual ROTH Conference on Monday, March 10 th at 10:00am Pacific Time in Dana Point, CA.
Sign-up for Aerie Pharmaceuticals to Present at the 26th Annual ROTH Conference investment picks
2014/2/27
Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) today announced that the Company will present at the Cowen and Company 34 th Annual Health Care Conference on Tuesday, March 4 th at 10:40 a.m. Eastern Time in Boston, MA.
Sign-up for Aerie Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference investment picks
2014/2/19
Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido, Jr., Ph.D., chairman and chief executive officer, will present in a fireside chat discussion at the RBC Capital Markets Global Healthcare Conference on Wednesday, February 26 th at 8:00 a.m. Eastern Time in New York, NY.
Sign-up for Aerie Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference investment picks
2014/3/11
BURLINGAME, Calif.
Sign-up for AeroCentury Corp. Reports Fourth Quarter 2013 And Full Year 2013 Results investment picks
2013/8/6
BURLINGAME, Calif.
Sign-up for AeroCentury Corp. Reports Second Quarter 2013 Results investment picks
2013/11/8
BURLINGAME, Calif.
Sign-up for AeroCentury Corp. Reports Third Quarter 2013 Results investment picks
2013/11/7
Aeroflex Holding Corp.
Sign-up for Aeroflex Announces First Quarter Fiscal 2014 Results investment picks
Aeroflex Holding Corp.
Sign-up for Aeroflex Announces Fourth Quarter and Full Year Fiscal 2013 Results investment picks
Aeroflex Incorporated (“Aeroflex”), a wholly owned subsidiary of Aeroflex Holding Corp.
Sign-up for Aeroflex Announces New Vice President and COO for Aeroflex Microelectronic Solutions HiRel Businesses investment picks
2014/2/7
Aeroflex Holding Corp.
Sign-up for Aeroflex Announces Second Quarter Fiscal 2014 Results investment picks
Aeroflex Holding Corp.
Sign-up for Aeroflex Announces the Sale of Aeroflex Test Equipment Services investment picks
2013/10/23
Aeroflex Holding Corp.
Sign-up for Aeroflex Plans to Release First Quarter Fiscal 2014 Financial Results on November 7, 2013 investment picks
2013/7/31
Aeroflex Holding Corp.
Sign-up for Aeroflex Plans to Release Fourth Quarter and Full Year Fiscal 2013 Financial Results on August 15, 2013 investment picks
Aeroflex Holding Corp.
Sign-up for Aeroflex Plans to Release Second Quarter Fiscal 2014 Financial Results on February 7, 2014 investment picks
2014/4/17
Aeroflex Holding Corp.
Sign-up for Aeroflex Plans to Release Third Quarter Fiscal 2014 Financial Results on May 7, 2014 investment picks
Aeroflex Holding Corp.
Sign-up for Aeroflex to Participate in Investor Conferences investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AEP To Bid On Canadian Transmission Project to Aeroflex to Participate in Investor Conferences
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity